Patient-Support-Program on Bioeconhttps://en.bioecon.ru/technologies/patient-support-program/Recent content in Patient-Support-Program on BioeconHugoen-USSun, 28 Jun 2026 22:16:20 +0700Named-patient programs & compassionate usehttps://en.bioecon.ru/technology/named-patient-compassionate-use/Sun, 28 Jun 2026 00:00:00 +0000https://en.bioecon.ru/technology/named-patient-compassionate-use/Regulated pre-approval access to investigational biopharmaceuticals for patients with serious or life-threatening disease and no satisfactory alternative — operated as a managed-access service spanning eligibility, regulatory submission, GMP drug sourcing and pharmacovigilance.